Isis Pharmaceuticals, Inc. (ISIS) Higher After Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts ISIS Hot Sheet
Price: $57.56 --0%
Financial Fact:
Basic net loss (in dollars per share): 0.06
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Basic net loss (in dollars per share): 0.06
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) are trading higher after the company reported Q2 EPS of ($0.01), $0.09 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $47.3 million versus the consensus estimate of $40.06 million.
For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.
For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Rivian reports Q3 2026 production of 19,751 vehicles
- Cuprina to buy seven-clinic Singapore healthcare group for S$4M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
